Effects of Photo-Biomodulation in Stargardt Disease.
Sergio Zaccaria ScalinciNicola ValsecchiPacella ElenaEdoardo Trovato BattagliolaPublished in: Clinical ophthalmology (Auckland, N.Z.) (2022)
BCVA, PERG, and MP-1 significantly improved 1 year after treatment. Also, improvement of PERG N35-P50 amplitude at 3 and 6 months was correlated to BCVA improvement at 1 year, suggesting that PERG could be useful in predicting visual outcome after photo-biomodulation.